FDA Application
-
NDC Search Results on Active Ingredient: acetaminophen
Click on Active Ingredient to view the label.
Ingredient Name | NDC | Company Name | Application Number or Regulatory Citation | Product Type | Marketing Category |
---|---|---|---|---|---|
ACETAMINOPHEN | 50332-0108-7 | HART Health | part343 | HUMAN OTC DRUG | OTC monograph not final |
ACETAMINOPHEN | 50332-0108-8 | HART Health | part343 | HUMAN OTC DRUG | OTC monograph not final |
CAFFEINE; MAGNESIUM SALICYLATE; ACETAMINOPHEN | 50332-0116-2 | HART Health | part343 | HUMAN OTC DRUG | OTC monograph not final |
CAFFEINE; MAGNESIUM SALICYLATE; ACETAMINOPHEN | 50332-0116-4 | HART Health | part343 | HUMAN OTC DRUG | OTC monograph not final |
CHLORPHENIRAMINE MALEATE; ACETAMINOPHEN; PHENYLEPHRINE HYDROCHLORIDE | 50332-0127-4 | NorMed | part343 | HUMAN OTC DRUG | OTC monograph not final |
CHLORPHENIRAMINE MALEATE; ACETAMINOPHEN; PHENYLEPHRINE HYDROCHLORIDE | 50332-0127-7 | NorMed | part343 | HUMAN OTC DRUG | OTC monograph not final |
PHENYLEPHRINE HYDROCHLORIDE; ACETAMINOPHEN; GUAIFENESIN; DEXTROMETHORPHAN HYDROBROMIDE | 50332-0129-4 | HART Health | part343 | HUMAN OTC DRUG | OTC monograph not final |
PHENYLEPHRINE HYDROCHLORIDE; ACETAMINOPHEN; GUAIFENESIN; DEXTROMETHORPHAN HYDROBROMIDE | 50332-0129-7 | HART Health | part343 | HUMAN OTC DRUG | OTC monograph not final |
GUAIFENESIN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE; ACETAMINOPHEN | 50332-0141-3 | HART Health | part341 | HUMAN OTC DRUG | OTC monograph final |
GUAIFENESIN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE; ACETAMINOPHEN | 50332-0141-4 | HART Health | part341 | HUMAN OTC DRUG | OTC monograph final |
GUAIFENESIN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE; ACETAMINOPHEN | 50332-0141-7 | HART Health | part341 | HUMAN OTC DRUG | OTC monograph final |
PYRILAMINE MALEATE; ACETAMINOPHEN; PAMABROM | 50332-0145-4 | HART Health | part343 | HUMAN OTC DRUG | OTC monograph not final |
PYRILAMINE MALEATE; ACETAMINOPHEN; PAMABROM | 50332-0145-7 | HART Health | part343 | HUMAN OTC DRUG | OTC monograph not final |
ACETAMINOPHEN | 50332-0148-1 | HART Health | part343 | HUMAN OTC DRUG | OTC monograph not final |
ACETAMINOPHEN | 50332-0148-4 | HART Health | part343 | HUMAN OTC DRUG | OTC monograph not final |
ACETAMINOPHEN | 50332-0148-7 | HART Health | part343 | HUMAN OTC DRUG | OTC monograph not final |
ACETAMINOPHEN | 50332-0148-8 | HART Health | part343 | HUMAN OTC DRUG | OTC monograph not final |
ACETAMINOPHEN | 50332-0149-1 | HART Health | part343 | HUMAN OTC DRUG | OTC monograph not final |
ACETAMINOPHEN | 50332-0149-3 | HART Health | part343 | HUMAN OTC DRUG | OTC monograph not final |
ACETAMINOPHEN | 50332-0149-4 | HART Health | part343 | HUMAN OTC DRUG | OTC monograph not final |
ACETAMINOPHEN | 50332-0149-7 | HART Health | part343 | HUMAN OTC DRUG | OTC monograph not final |
ACETAMINOPHEN | 50332-0149-8 | HART Health | part343 | HUMAN OTC DRUG | OTC monograph not final |
CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE; ACETAMINOPHEN | 50332-0153-4 | HART Health | M | HUMAN OTC DRUG | OTC Monograph Drug |
CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE; ACETAMINOPHEN | 50332-0153-7 | HART Health | M | HUMAN OTC DRUG | OTC Monograph Drug |
ACETAMINOPHEN; CODEINE PHOSPHATE | 50383-079-16 | Akorn | ANDA040119 | HUMAN PRESCRIPTION DRUG | ANDA |
ACETAMINOPHEN; CODEINE PHOSPHATE | 50383-337-05 | Akorn | ANDA040119 | HUMAN PRESCRIPTION DRUG | ANDA |
ACETAMINOPHEN; CODEINE PHOSPHATE | 50383-337-06 | Akorn | ANDA040119 | HUMAN PRESCRIPTION DRUG | ANDA |
CODEINE PHOSPHATE; ACETAMINOPHEN | 50383-338-10 | Akorn | ANDA040119 | HUMAN PRESCRIPTION DRUG | ANDA |
CODEINE PHOSPHATE; ACETAMINOPHEN | 50383-338-11 | Akorn | ANDA040119 | HUMAN PRESCRIPTION DRUG | ANDA |
CODEINE PHOSPHATE; ACETAMINOPHEN | 50383-339-12 | Akorn | ANDA040119 | HUMAN PRESCRIPTION DRUG | ANDA |
-